Predictivity of Human Telomerase Reverse Transcriptase (h-TERT) in Oral Squamous Cell Carcinoma: Immunohistochemical Study

Eman Mosaad

Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.

Heba Ahmed Elhendawy *

Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.

Mena Mahfouz

Pathology Department, Faculty of Medicine, Mansoura University, Egypt.

Nadia Abbas Ibrahim El-sissy

Oral Pathology Department, Faculty of Dentistry, Mansoura University, Egypt.

*Author to whom correspondence should be addressed.


Abstract

Aims: Determine the potential role of h-TERT as a prognostic marker for oral squamous cell carcinoma by evaluating its immunohistochemical expression in different OSCC histologic grades in comparison with normal oral mucosa.

Study Design: A retrospective study.

Place and Duration: Oncology Center, Mansoura University, and Oral Pathology Department, Faculty of Dentistry, Mansoura University. The worked sample selected from the years (2015-2019).

Methodology: Our study was accomplished on 30 OSCC cases and a control group of normal oral mucosa. Histopathologic grading of OSCCs was made using the WHO grade and Anneroth`s grading systems. Immunohistochemical expression of h-TERT was assessed in relation to different clinicopathological parameters. The data was analyzed using Pearson`s chi-square test to compare the differences between groups. Spearman's correlation co-efficiency test was used to test the association between different variables. A P value ≤ 0.05 was considered to be statistically significant.

Results: A significant increased h-TERT expression was recorded from normal to OSCC groups (P=0.000). Additionally, elevated h-TERT expression was significantly correlated with the higher carcinoma histologic grade (P =0.025). There were high statistically significant differences in h-TERT expression concerning the parameters; Anneroth pattern of invasion (P= 0.049), depth of invasion (DOI, P=0.024), and lymphoplasmacytic infiltration (LPI, P=0.009). There were no statistically significant differences in h-TERT immunoexpression considering the clinical parameters; patient age, gender, anatomical sites, clinical shape of lesion, T, N, M, and TNM stages (Chi-square test, P values were > 0.05).

Conclusions: Increased h-TERT immunoexpression from normal to OSCC groups suggests its involvement in malignant transformation. Additionally, the significant differential expression of h-TERT among different OSCC histologic grades signaling its valuable use as a biomarker for assessing the cellular malignant progression of oral carcinomas, but unreliable as a clinical tumor progression marker. Moreover, the significant correlation of h-TERT expression with LPI, DOI and pattern of invasion indicating its possible reliable role in tumor host relation during multistage carcinogenesis.

Keywords: Oral squamous cell carcinoma, human telomerase reverse transcriptase, immunohistochemistry, predictive marker


How to Cite

Mosaad , Eman, Heba Ahmed Elhendawy, Mena Mahfouz, and Nadia Abbas Ibrahim El-sissy. 2023. “Predictivity of Human Telomerase Reverse Transcriptase (h-TERT) in Oral Squamous Cell Carcinoma: Immunohistochemical Study”. Journal of Cancer and Tumor International 13 (3):28-41. https://doi.org/10.9734/jcti/2023/v13i3237.

Downloads

Download data is not yet available.

References

Coletta RD, Yeudall WA, Salo T. Grand challenges in oral cancers. Frontiers in oral health. 2020;1:3.

Regezi Joseph A, James Sciubba RCJ. Oral pathology: Clinical pathologic correlations, 7th ed. In: chapter 2 :ulcerative condition. 7th editio. 2017;59.

Shafer Hine L. Shafer’s textbook in oral pathology. In: Sivapathasundharam B, editor. chapter 5 : Epithelial neoplasms of oral cavity [Internet]. 9th editio. 2020;169,159. Available:https://books.google.com.eg/books?id=WnhtAwAAQBAJ&printsec=frontcover&dq=inauthor:%22B+Sivapathasundharam%22&hl=ar&sa=X&redir_esc=y#v=onepage&q&f=false

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Nocini R, Lippi G, Mattiuzzi C. Biological and epidemiologic updates on lip and oral cavity cancers. Ann Cancer Epidemiol. 2020;4(1):1-6.

Fan HC, Chang FW, Tsai JD, Lin KM, Chen CM, Lin SZ, Liu CA, Harn HJ. Telomeres and cancer. Life. 2021; 11(12):1405.

Victorelli S, Passos JF. EBioMedicine Telomeres and Cell Senescence - Size Matters Not. EBioMedicine [Internet]. 2017;21:14–20. Available:http://dx.doi.org/10.1016/j.ebiom.2017.03.027

Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome medicine. 2016;8:1-8.

Rosen J, Jakobs P, Ale-Agha N, Altschmied J, Haendeler J. Non-canonical functions of Telomerase Reverse Transcriptase–Impact on redox homeostasis. Redox Biology. 2020; 34:101543.

Wang K, Wang RL, Liu JJ, Zhou J, Li X, Hu WW, Jiang WJ, Hao NB. The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis. Medicine. 2018;97(35).

Yuan X, Yuan H, Zhang N, Liu T, Xu D. Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance. Clinical and Translational Medicine. 2022;12(11):e1111.

Donati B, Ciarrocchi A. Telomerase and telomeres biology in thyroid cancer. Int J Mol Sci. 2019;20(12):1–17.

in der Stroth L, Tharehalli U, Günes C, Lechel A. Telomeres and telomerase in the development of liver cancer. Cancers. 2020;12(8):2048.

Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.

Gomatou G, Masaoutis C, Vamvakaris I, Kotteas E, Bouros E, Tzilas V, Bouros D. Differential immunohistochemical expression of hTERT in lung cancer patients with and without idiopathic pulmonary fibrosis. Pulmonology; 2022.

Siraj AK, Bu R, Iqbal K, Parvathareddy SK, Siraj N, Siraj S, Diaz MR, Rala DR, Benito AD, Sabido MA, Al-Rasheed M. Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population. Genomics. 2020; 112(2):1746-53.

Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res. 1987;95(3):229–49.

Boscolo-Rizzo P, Da Mosto MC, Rampazzo E, Giunco S, Del Mistro A, Menegaldo A, et al. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Rev. 2016;35(3):457–74.

Raju K L, Haragannavar VC, Patil S, Rao RS, Nagaraj T, Augustine D, et al. Expression of hTERT in oral submucous fibrosis and oral squamous cell carcinoma – An immunohistochemical analysis. Pathol Oncol Res. 2020; 26(3): 1573–82.

Wan S, Wan F, Wan P, Wan J, He X, Liu F, et al. The relation of microsatellite instability to expression of hTERT in human gastric carcinoma. 2019;12:2257–63.

Rai A, Naikmasur VG, Sattur A. Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma. Indian J Med Paediatr Oncol. 2016;37(3):183–8.

Haraguchi K, Habu M, Yada N, Sasaguri M, Yoshioka I, Tominaga K. Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma. Int J Clin Exp Pathol [Internet]. 2022;15(1):29–37 Available:http://www.ncbi.nlm.nih.gov/pubmed/35145581%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8822205

Raghunandan B, Sanjai K, Kumaraswamy J, Papaiah L, Pandey B, Jyothi B. Expression of human telomerase reverse transcriptase protein in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol. 2016; 20(1):96–101.

Kohli JS, Mir H, Wasif A, Chong H, Akhras V, Kumar R, et al. ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression. Oncotarget. 2017;8(61):104408–17.

Bustos BDU, Torralba AS, Poveda PM, Simó GP, Farinos JS, Ros ML, et al. Telomerase Expression in a Series of Melanocytic Neoplasms. Actas Dermosifiliogr. 2019;110(3):212–9.

Zou Y, Cong Y sheng, Zhou J. Implications of telomerase reverse transcriptase in tumor metastasis. BMB Rep. 2020; 53(9):458–65.

Prasad RR, Mishra DK, Kumar M, Yadava PK. Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation. Heliyon. 2022;8(1).

Xian S, Dosset M, Castro A, Carter H, Zanetti M. Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. PNAS Nexus [Internet]. 2023; 2(3):1–13.

Available:https://doi.org/10.1093/pnasnexus/pgad046